HGH-Fragment 176-191

Overview
HGH Fragment 176–191 is a C-terminal segment of human growth hormone commonly explored in preclinical research on adipocyte biology, lipid turnover, and metabolic signaling. We keep things straightforward: clean labeling, clarity-first specs, and access to batch documentation so you can verify exactly what you’re working with.

Key research highlights (in plain terms)

• Adipocyte signaling & lipid balance — used in cell and tissue models to examine markers linked to lipolysis vs. lipogenesis (e.g., glycerol release, fatty-acid mobilization) under controlled conditions.

• Metabolic readouts — applied in workflows that track energy-use indicators and pathway activity in fat cells, connecting receptor-level signals to measurable outcomes.

• Dose–response & time-course — suited for experiments that profile concentration effects and exposure windows, enabling clean comparisons across assay runs.

• Comparative assays — useful for side-by-side studies versus full-length hGH or related peptides to evaluate selectivity, downstream markers, and model-specific responses.

Why Pegasus

• Purity you can verify: batch testing with documentation (COA available)

• Clarity in every vial: straightforward specs and labeling

• Consistency you can trust: stable sourcing and careful handling

Specifications

• Form: Lyophilized powder

• Identity: Human growth hormone fragment 176–191 (C-terminal peptide)

• Appearance: White to off-white

• Purity: ≥98% (HPLC)

• Solubility: Sterile water or appropriate buffer (optimize per protocol)

• Packaging: Labeled vial with lot and batch ID

Storage & handling

• Store dry at −20 °C, protected from light and moisture

• After reconstitution, aliquot and store at −20 °C; avoid repeated freeze–thaw cycles

Included with your order

• Labeled vial of HGH Fragment 176–191 (research grade)

• Batch/lot ID with access to testing details (COA)